389. Anti-TNF treatments for women with chronic inflammatory diseases: Comparing attitudes and perceptions of physicians in Europe and the US
Sign Up to like & getrecommendations! Published in 2018 at "Pregnancy Hypertension"
DOI: 10.1016/j.preghy.2018.08.423
Abstract: Introduction Chronic inflammatory disease (CID) activity in Women of Childbearing Age (WoCBA) is associated with higher risk of pregnancy complications and adverse outcomes. Tumour necrosis factor antagonists (anti-TNFs) are effective, but data on utilisation for… read more here.
Keywords: anti tnf; anti tnfs; pregnancy; eu5 ... See more keywords
FRI0692 Anti-tnf treatments for women with chronic inflammatory diseases: comparing attitudes and perceptions of physicians in europe and the us
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.1919
Abstract: Background: For Women of Childbearing Age (WoCBA) with chronic inflammatory diseases (CID), onset, diagnosis and treatment initiation often overlap with peak reproductive years. High disease activity is associated with increased risk of pregnancy complications and… read more here.
Keywords: pregnancy; ucb pharma; anti tnf; anti tnfs ... See more keywords
Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study
Sign Up to like & getrecommendations! Published in 2019 at "Gut"
DOI: 10.1136/gutjnl-2019-318932
Abstract: Objective Patients with IBD are at increased risk of acute arterial events. Antitumour necrosis factor (TNF) agents and thiopurines may, via their anti-inflammatory properties, lower the risk of acute arterial events. The aim of this… read more here.
Keywords: risk acute; arterial events; disease; acute arterial ... See more keywords